Figure 1From: Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study Kaplan-Meyer estimates of time-to progression (a) and overall survival (b) for 70 patients selected for the analysis. Back to article page